Pharmacy coalitions are urging Congress to enact immediate PBM reforms to address prescription drug costs and pharmacy closures, emphasizing the need for transparency, adequate reimbursement, and the elimination of harmful PBM practices.
NACDS emphasizes Administration’s commitments on PBM reform legislation and urges partnership with pharmacies to battle chronic disease.
NACDS’ recommendations include partnering with pharmacies to address the chronic disease crisis.
January 22 Squawk on the Street highlights need for PBM reform, a key piece of NACDS’ “Four Wins to Make America Healthy Again”
In December, President Trump pledged to take on the middlemen in two national TV appearances in one week
“This is an important moment to fix lingering and devastating problems and to leverage tremendous opportunities for Americans and for the pharmacies and pharmacists who serve them.”
The move by HHS will help maintain continuity of patients’ access to pharmacies as states continue to achieve strong progress in enhancing their policies
NACDS also praises Congressional engagement to prevent disruptions of patients’ access to prescription drugs through no fault of dispensers.
NACDS' focus on Food Is Medicine and Nourish My Health is part of the NACDS Health and Wellness Innovation Initiative
This situation jeopardizes patients' access to prescription drugs, through no fault of dispensers.
On September 17, NACDS and representatives from NACDS member pharmacies participated in a meeting with the White House Office of Pandemic Preparedness and Response Policy to discuss pharmacy needs for the current respiratory season as well as future, potential response efforts. Pictured here left to right on the front row are Sara Roszak, NACDS’ senior vice president of health and wellness strategy and policy; Anita Patel, vice president of pharmacy services development, Walgreen Co.; and Doug Cornelius, director of pharmacy operations, Kroger Health. Pictured in the back row left to right are Lisa Smith, senior director II, clinical operations and strategy, Walmart Health and Wellness; Summer Kerley, group vice president of pharmacy growth and operations, Rite Aid Corporation; past NACDS Chair Mike Wysong, chief executive officer of CARE Pharmacies; Charley John, senior director of healthcare policy and strategy, Walgreen Co.; NACDS President and CEO Steven C. Anderson; and Nimesh Jhaveri, executive vice president and chief impact officer, McKesson Corporation.
RELATED CONTENT
HHS Releases National Public Education Campaign for Respiratory Virus Season
